The 8th Edition Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 25 - 26 March 2021 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data.
Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
Senior Scientist, Cellular Technology Limited, USA
CEO and Founder, Thirty-Six
Chief Executive Officer, Precision Antibody, USA
Ph.D. Technical Product Manager, Abcam
VP, Medical Director, Ultivue, USA
Senior Scientific Program Manager, Agilent Technologies, USA
Scientific Director, Companion Diagnostics, Exosome Diagnostics, Germany
Director Oncology & Precision Diagnostics, QIAGEN, Germany
Head of CBCEL, Brunel University London, UK
Pathologist, Companion Diagnostics, Agilent Technologies, USA
Associate Director, Translational Oncology, Takeda Pharmaceuticals, USA
Executive Vice President, Chief Medical Officer, Eikon Therapeutics